Correlation Between DiaMedica Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on DiaMedica Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for DiaMedica Therapeutics and Mineralys Therapeutics,
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between DiaMedica and Mineralys is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.66 times more return on investment than Mineralys Therapeutics,. However, DiaMedica Therapeutics is 1.52 times less risky than Mineralys Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.05 per unit of risk. If you would invest 430.00 in DiaMedica Therapeutics on August 28, 2024 and sell it today you would earn a total of 32.00 from holding DiaMedica Therapeutics or generate 7.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
DiaMedica Therapeutics vs. Mineralys Therapeutics, Common
Performance |
Timeline |
DiaMedica Therapeutics |
Mineralys Therapeutics, |
DiaMedica Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with DiaMedica Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite DiaMedica Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.DiaMedica Therapeutics vs. Eliem Therapeutics | DiaMedica Therapeutics vs. HCW Biologics | DiaMedica Therapeutics vs. Scpharmaceuticals | DiaMedica Therapeutics vs. Milestone Pharmaceuticals |
Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |